$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Latest information on domestic marketing progress and approved indications of cobimetinib (cobimetinib)
2026-02-01 22:25:32
Check Details
How long does it take to effectively reduce pulmonary arterial hypertension after taking macitentan (Aopuxil)?
2026-02-01 22:25:32
Check Details
What is the difference between Tilidine and Tilorisen (Huacosi)? Why is it not recommended for some patients?
2026-02-01 22:25:32
Check Details
Comparison of the efficacy of Pretomanid and other anti-tuberculosis drugs and clinical analysis of combined drug regimens
2026-02-01 22:25:32
Check Details
Comparison of the three most popular brands of voclosporin and their efficacy and market evaluation
2026-02-01 22:25:32
Check Details
Clinical reference guide for drugs and next treatment options after ponatinib resistance
2026-02-01 22:25:32
Check Details
Whether Shafinamide Tablets (Siddaco) is banned by the state and the status of domestic drug supervision and approval
2026-02-01 22:25:32
Check Details
Tarlatamab-Imdelltra market price, patient purchase channels and reference cost instructions
2026-02-01 22:25:32
Check Details
Telisotuzumab-Optional treatment options and clinical research summary after EMRELIS resistance
2026-02-01 22:25:32
Check Details
Are tovorafenib and tovatinib the same and analysis of differences in pharmacological effects and indications
2026-02-01 22:25:32
Check Details
Effect and clinical research summary of vorasidenib-VORANIGO in the treatment of vulvovaginal candidiasis
2026-02-01 22:25:32
Check Details
Are zongertinib and zonertinib the same and analysis of differences in pharmacological effects and clinical applications
2026-02-01 22:25:32
Check Details
1
2
...
2292
2293
2294
2295
2296
2297
2298
...
10214
10215
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Niraparib: A PARP Inhibitor for Ovarian Cancer Maintenance Therapy
2
Abiraterone Acetate: CYP17 Inhibitor for Advanced Prostate Cancer
3
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation
4
Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis
5
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
6
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
7
Trelagliptin: The First Once-Weekly DPP-4 Inhibitor Revolutionizing Type 2 Diabetes Care
8
Adagrasib Medication Management Guide for Special Populations
9
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
10
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
11
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
12
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition